| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/2001 | EP1073416A1 Use of inhaled no as anti-inflammatory agent |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | EP1073413A1 Methods and compositions for stabilizing acetylcholine compositions |
| 02/07/2001 | EP1073401A1 Topical anesthetic formulation |
| 02/07/2001 | EP1073333A1 S-rabeprazole compositions and methods |
| 02/07/2001 | EP1073332A1 R-rabeprazole compositions and methods |
| 02/07/2001 | EP1023103A4 Fluid delivery device with temperature controlled energy source |
| 02/07/2001 | EP1021165A4 Bioerodable polymeric adhesives for tissue repair |
| 02/07/2001 | EP0904084A4 Emergency contraceptive kit |
| 02/07/2001 | EP0696921B1 Veterinary composition containing a proton pump inhibitor |
| 02/07/2001 | CN2417889Y Composite plaster sheet for diminishing relaxing of under eye and black halo around eyes |
| 02/07/2001 | CN1283123A Sustained release medicinal compositions |
| 02/07/2001 | CN1283122A Sustained release medicinal compositions |
| 02/07/2001 | CN1283119A Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 02/07/2001 | CN1283117A Orally administrable solid ribavirin dosafe forms and process for making them |
| 02/07/2001 | CN1283112A Sustained release formulation containing three different types of polymers and tablet formed therefrom |
| 02/07/2001 | CN1283111A Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
| 02/07/2001 | CN1283110A Tablet for instant and prolonged release of one or more active substances |
| 02/07/2001 | CN1283109A Method for making a pharmaceutical formulation |
| 02/07/2001 | CN1283107A Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates |
| 02/07/2001 | CN1283106A Pharmaceutical compositions comprising micelles comprising lipophilic glucoiorticosteroid and only one surfactant |
| 02/07/2001 | CN1283105A Water-soluble eye drop |
| 02/07/2001 | CN1283083A Revitalisation formulation |
| 02/07/2001 | CN1282612A Antituberculotic aerosol composition and its preparing process |
| 02/07/2001 | CN1282610A Medicine for treating gastrointestinal diseases and its preparing process |
| 02/07/2001 | CN1282603A Exterior-applied Chinese medicine for treating bone fracture and its preparing process |
| 02/07/2001 | CN1282598A Particles of antidiarrheal Xiangzhu decoction |
| 02/07/2001 | CN1282593A Oral liquid for treating piles |
| 02/07/2001 | CN1282586A Application of soft-shelled turtle blood |
| 02/07/2001 | CN1282584A Application of icariin in preventing and treating sexual disfunction and improving diseases associated with vasoconstriction |
| 02/07/2001 | CN1282583A Exterior-applied ointment |
| 02/07/2001 | CN1282581A Medicine composition |
| 02/07/2001 | CN1282580A Release-controlling coating of antineoplastic leurocristine |
| 02/07/2001 | CN1282578A Release-controlling coating of antineoplastic lomustine |
| 02/07/2001 | CN1061562C Capsule for treating glycuresis |
| 02/07/2001 | CN1061558C Ginkgo and calcium capsule |
| 02/07/2001 | CN1061549C Guanxiashu inhalation for coranary heart disease and its production process |
| 02/07/2001 | CN1061544C Compound epimedium ointment |
| 02/07/2001 | CN1061541C Dianyansan powder medicine for acute waist sprain and preparation method thereof |
| 02/07/2001 | CN1061540C Anti-radiation health care liquid and preparation method thereof |
| 02/07/2001 | CN1061536C Tablet for clearing head for cerebrorascular disease |
| 02/06/2001 | US6185453 Iontophoretic device including specified integrin inhibitors such as n3-(2-(3-(4-formamidinophenyl)-isoxazolin-5(r,s)-yl)-acetyl)-n2 -(phenylsulfonyl)-2,3-(s)-diaminopropanoic acid |
| 02/06/2001 | US6184266 Providing crosslinkable polymer, crosslinking crosslinkable polymerand shaping crosslinked polymer to form device; deforming by crosslinking |
| 02/06/2001 | US6184250 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
| 02/06/2001 | US6184220 Low viscosity acid enolcarboxamide non-steroidal antiinflammatory drug (nsaid) suspension stabilised by a low concentration of dispersed silica in the presence of a water soluble cellulose ether |
| 02/06/2001 | US6184213 Diluent and disintegrating composition, its method of achievement and its use |
| 02/06/2001 | US6184037 Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| 02/06/2001 | US6184009 Process for the preparation of materials with a high content of conjugated long chain polyunsaturated fatty acids |
| 02/06/2001 | US6183845 Multiple layer softgel |
| 02/06/2001 | US6183808 Thin film coatings from tapioca dextrin mixed for coating, water suspension and detackifier with nonaqueous ingredients, applying and drying |
| 02/06/2001 | US6183783 Bringing the suspension of an active material and a polar polymer insoluble in co2 into contact with liquid co2 so as to desolvate in a controlled way the substantially polar polymer and to provide its coacervation |
| 02/06/2001 | US6183782 Inhalation composition containing lactose pellets |
| 02/06/2001 | US6183781 Implantable polymer/drug matrix mass; fragmenting a solid polymer/drug matrix at a temperature below the glass transition temperature of the solid polymer/drug matrix; compressing the polymer/drug matrix microparticles |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183779 Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
| 02/06/2001 | US6183778 Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
| 02/06/2001 | US6183777 Controlled release tacrine dosage form |
| 02/06/2001 | US6183776 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183774 Long chain fatty acid salt of n,n-dimethylalkanediamine |
| 02/06/2001 | US6183772 Doped liposomes comprise: a) a plurality of polymerized diynes; b) one or more ligands having an affinity for said analyte; and c) a dopant having no affinity for said analyte. |
| 02/06/2001 | US6183771 Transdermal compositions containing levosimendan |
| 02/06/2001 | US6183770 Delivery of agents to the skin for local skin treatment may be desirable to improve the health and appearance of the skin. |
| 02/06/2001 | US6183768 Implantable medicine releasing corpuscles and method of making, implanting and removing the same |
| 02/06/2001 | US6183766 Lipophilic skin moisturizing agent; degreasing agent selected from the group consisting of: silicones, wax materials, powders, fluorochemicals and mixtures thereof; optionally a thickener, a humectant, a perfume; and water. |
| 02/06/2001 | US6183762 Method for preparing the emulsions and the use of the emulsions in various domestic and industrial compositions. |
| 02/06/2001 | US6183737 Bonding of cartilage pieces using isolated chondrocytes and a biological gel |
| 02/06/2001 | US6183732 Chemical composition |
| 02/06/2001 | US6183719 High surface area alumina solid |
| 02/06/2001 | US6183466 Dosage form comprising a capsule |
| 02/06/2001 | US6183451 Method of delivery of skin treatment agents using freeze-dried liposomes |
| 02/06/2001 | US6183251 Scalloped dental trays for use in treating teeth with sticky dental compositions |
| 02/06/2001 | CA2220696C Improved method for controlling ectoparasites |
| 02/06/2001 | CA2141572C Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/06/2001 | CA2119654C Particles for nmr imaging and method of manufacture |
| 02/01/2001 | WO2001008421A2 Tablet for programmed drug release |
| 02/01/2001 | WO2001007507A1 Pullulan film compositions |
| 02/01/2001 | WO2001007198A1 Apparatus and methods for alternating laser treatment of pharmaceutical dispensers |
| 02/01/2001 | WO2001007096A1 Plaster for introducing pharmaceutical compositions in living organisms |
| 02/01/2001 | WO2001007079A1 Improvements in dispensing vaccines |
| 02/01/2001 | WO2001007067A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2001007058A2 Parenteral cisplatin emulsion |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007049A2 Ophthalmic composition comprising ketotifen |
| 02/01/2001 | WO2001007041A1 Antiarrhythmic drug |
| 02/01/2001 | WO2001007033A2 Neuroprotective pharmaceutical reparations comprising p-fluoroselegiline |
| 02/01/2001 | WO2001007018A1 Patches for external use |
| 02/01/2001 | WO2001007017A1 Transdermal therapeutic system for administering a calcium antagonist |
| 02/01/2001 | WO2001007016A1 Process for the production of soft capsules and coating materials and lubricants to be used therefor |
| 02/01/2001 | WO2001007015A2 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 02/01/2001 | WO2001007014A1 Formulations of steroid solutions for inhalatory administration |
| 02/01/2001 | WO2001007011A1 Method for releasing an agent from a red blood cell |
| 02/01/2001 | WO2001006993A1 Oil-in-water emulsion composition |
| 02/01/2001 | WO2001006991A1 Oil-in-water emulsion with improved stability |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006987A2 Transnasal anticonvulsive compositions and modulated process |
| 02/01/2001 | WO2001006985A2 Select amino acids as zinc-solubilizing agents in anti-viral genital formulations |
| 02/01/2001 | WO2001006982A2 Low-dose tablets and preparation method |